Planet Labs PBC (PL) 10-Q 6 Jun 24 2025 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Apr. 30, 2024	Jun. 03, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2024
Document Transition Report	false
Entity File Number	001-40166
Entity Registrant Name	Planet Labs PBC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-4299396
Entity Address, Address Line One	645 Harrison Street
Entity Address, Address Line Two	Floor 4
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94107
City Area Code	415
Local Phone Number	829-3313
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001836833
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--01-31
Common Class A
Document Information [Line Items]
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	PL
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		269,614,188
Warrant
Document Information [Line Items]
Title of 12(b) Security	Warrants to purchase Class A common stock, at an exercise price of $11.50 per share
Trading Symbol	PL WS
Security Exchange Name	NYSE
Common Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		21,157,586

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Current assets
Cash and cash equivalents	$ 107,367	$ 83,866
Restricted cash and cash equivalents, current	8,802	8,360
Short-term investments	168,218	215,041
Accounts receivable, net of allowance of $895 and $1,539, respectively	38,527	43,320
Prepaid expenses and other current assets	23,044	19,564
Total current assets	345,958	370,151
Property and equipment, net	111,338	113,429
Capitalized internal-use software, net	16,066	14,973
Goodwill	137,110	136,256
Intangible assets, net	31,403	32,448
Restricted cash and cash equivalents, non-current	9,564	9,972
Operating lease right-of-use assets	20,966	22,339
Other non-current assets	2,199	2,429
Total assets	674,604	701,997
Current liabilities
Accounts payable	3,131	2,601
Accrued and other current liabilities	43,361	44,779
Deferred revenue	63,646	72,327
Liability from early exercise of stock options	8,068	8,964
Operating lease liabilities, current	8,175	7,978
Total current liabilities	126,381	136,649
Deferred revenue	13,247	5,293
Deferred hosting costs	9,261	7,101
Public and private placement warrant liabilities	1,431	2,961
Operating lease liabilities, non-current	15,207	16,952
Contingent consideration	2,915	5,885
Other non-current liabilities	5,837	9,138
Total liabilities	174,279	183,979
Commitments and contingencies (Note 8)
Stockholders’ equity
Common stock, $0.0001 par value, 570,000,000, 30,000,000 and 30,000,000 Class A, Class B and Class C shares authorized at April 30, 2024 and January 31, 2024, 269,579,722 and 268,117,905 Class A shares issued and outstanding at April 30, 2024 and January 31, 2024, respectively, 21,157,586 Class B shares issued and outstanding at April 30, 2024 and January 31, 2024, 0 Class C shares issued and outstanding at April 30, 2024 and January 31, 2024 (1)	28	28
Additional paid-in capital	1,608,847	1,596,201
Accumulated other comprehensive income	548	1,594
Accumulated deficit	(1,109,098)	(1,079,805)
Total stockholders’ equity	500,325	518,018
Total liabilities and stockholders’ equity	$ 674,604	$ 701,997

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Accounts receivable, allowance	$ 895	$ 1,539
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common Class A
Common stock, shares authorized (in shares)	570,000,000	570,000,000
Common stock, shares issued (in shares)	269,579,722	268,117,905
Common stock, shares outstanding (in shares)	269,579,722	268,117,905
Common Class B
Common stock, shares authorized (in shares)	30,000,000	30,000,000
Common stock, shares issued (in shares)	21,157,586	21,157,586
Common stock, shares outstanding (in shares)	21,157,586	21,157,586
Common Class C
Common stock, shares authorized (in shares)	30,000,000	30,000,000
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Income Statement [Abstract]
Revenue	$ 60,440	$ 52,703
Cost of revenue	28,757	24,556
Gross profit	31,683	28,147
Operating expenses
Research and development	25,589	28,186
Sales and marketing	21,485	23,125
General and administrative	19,180	21,528
Total operating expenses	66,254	72,839
Loss from operations	(34,571)	(44,692)
Interest income	3,107	4,506
Change in fair value of warrant liabilities	1,530	5,945
Other income, net	1,083	104
Total other income, net	5,720	10,555
Loss before provision for income taxes	(28,851)	(34,137)
Provision for income taxes	442	307
Net loss	$ (29,293)	$ (34,444)
Basic and diluted net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.10)	$ (0.13)
Basic and diluted net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.10)	$ (0.13)
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders, basic (in shares)	288,268,718	272,347,977
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders, diluted (in shares)	288,268,718	272,347,977

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (29,293)	$ (34,444)
Other comprehensive loss, net of tax:
Foreign currency translation adjustment	(534)	(45)
Change in fair value of available-for-sale securities	(512)	(544)
Other comprehensive loss, net of tax	(1,046)	(589)
Comprehensive loss	$ (30,339)	$ (35,033)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023		271,783,561
Beginning balance at Jan. 31, 2023	$ 576,104	$ 27	$ 1,513,102	$ 2,271	$ (939,296)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock from the exercise of common stock options (in shares)		1,018,385
Issuance of Class A common stock from the exercise of common stock options	3,295		3,295
Issuance of Class A common stock upon vesting of restricted stock units (in shares)		1,278,161
Vesting of early exercised stock options (in shares)		91,911
Vesting of early exercised stock options	896		896
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)		(472,136)
Class A common stock withheld to satisfy employee tax withholding obligations	(1,896)		(1,896)
Stock-based compensation	15,983		15,983
Net unrealized loss on available-for-sale securities, net of taxes	(544)			(544)
Change in translation	(45)			(45)
Net loss	(34,444)				(34,444)
Ending balance (in shares) at Apr. 30, 2023		273,699,882
Ending balance at Apr. 30, 2023	559,349	$ 27	1,531,380	1,682	(973,740)
Beginning balance (in shares) at Jan. 31, 2024		289,275,491
Beginning balance at Jan. 31, 2024	$ 518,018	$ 28	1,596,201	1,594	(1,079,805)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock from the exercise of common stock options (in shares)	35,318	35,318
Issuance of Class A common stock from the exercise of common stock options	$ 20		20
Issuance of Class A common stock upon vesting of restricted stock units (in shares)		2,334,916
Vesting of early exercised stock options	896		896
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)		(908,417)
Class A common stock withheld to satisfy employee tax withholding obligations	(2,015)		(2,015)
Stock-based compensation	13,745		13,745
Net unrealized loss on available-for-sale securities, net of taxes	(512)			(512)
Change in translation	(534)			(534)
Net loss	(29,293)				(29,293)
Ending balance (in shares) at Apr. 30, 2024		290,737,308
Ending balance at Apr. 30, 2024	$ 500,325	$ 28	$ 1,608,847	$ 548	$ (1,109,098)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Operating activities
Net loss	$ (29,293)	$ (34,444)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	13,103	10,248
Stock-based compensation, net of capitalized cost of $673 and $627, respectively	13,072	15,356
Change in fair value of warrant liabilities	(1,530)	(5,945)
Change in fair value of contingent consideration	(101)	(423)
Other	(547)	(1,634)
Changes in operating assets and liabilities
Accounts receivable	5,482	(121)
Prepaid expenses and other assets	(731)	2,770
Accounts payable, accrued and other liabilities	(5,237)	(10,713)
Deferred revenue	(721)	(7,765)
Deferred hosting costs	2,206	2,070
Net cash used in operating activities	(4,297)	(30,601)
Investing activities
Purchases of property and equipment	(9,938)	(6,336)
Capitalized internal-use software	(1,418)	(739)
Maturities of available-for-sale securities	32,158	30,000
Sales of available-for-sale securities	43,116	0
Purchases of available-for-sale securities	(28,043)	(35,229)
Business acquisition, net of cash acquired	(1,068)	0
Purchases of licensed imagery	(4,024)	0
Other	(300)	(277)
Net cash provided by (used in) investing activities	30,483	(12,581)
Financing activities
Proceeds from the exercise of common stock options	20	3,295
Class A common stock withheld to satisfy employee tax withholding obligations	(2,015)	(1,896)
Other	(380)	0
Net cash provided by (used in) financing activities	(2,375)	1,399
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents	(276)	177
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents	23,535	(41,606)
Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period	102,198	188,076
Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period	$ 125,733	$ 146,470

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Statement of Cash Flows [Abstract]
Share-based payment arrangement, capitalized costs	$ 673	$ 627

Organization

Organization	3 Months Ended
	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization Planet Labs PBC (“Planet,” or the “Company”) was founded to design, construct, and launch constellations of satellites with the intent of providing high cadence geospatial data delivered to customers via an online platform. The Company’s mission is to use space to help life on Earth, by imaging the world every day and making global change visible, accessible, and actionable. The Company is headquartered in San Francisco, California, with operations throughout the United States ( “ U.S.”), Canada, Asia and Europe. On July 7, 2021, Planet Labs Inc. (“Former Planet”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with dMY Technology Group, Inc. IV (“dMY IV”), a special purpose acquisition company (“SPAC”) incorporated in Delaware on December 15, 2020, Photon Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of dMY IV (“First Merger Sub”), and Photon Merger Sub Two, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of dMY IV (“Second Merger Sub”). Pursuant to the Merger Agreement, upon the favorable vote of dMY IV’s stockholders on December 3, 2021, on December 7, 2021, First Merger Sub merged with and into Former Planet (the “Surviving Corporation”), with Former Planet surviving the merger as a wholly owned subsidiary of dMY IV (the “First Merger”), and pursuant to Former Planet’s election immediately following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation merged with and into dMY IV, with dMY IV surviving the merger (the “Business Combination”). Following the completion of the Business Combination, dMY IV was renamed Planet Labs PBC. Former Planet was incorporated in the state of Delaware on December 28, 2010. Former Planet was originally incorporated as Cosmogia Inc., and the name was subsequently changed to Planet Labs Inc. on June 24, 2013.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements are unaudited; however, in the opinion of management they include all normal and recurring adjustments necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements for the periods presented. Operating results for the three months ended April 30, 2024 are not necessarily indicative of the results expected for the fiscal year ending January 31, 2025 or any other future period. The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and include the accounts of Planet Labs PBC and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year end is January 31. Certain notes or other information that are normally required by U.S. GAAP have been condensed or omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2024 (the “2024 Form 10-K”). Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant estimates and assumptions that affect the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the useful lives of property and equipment, capitalized internal-use software and intangible assets, the Company’s incremental borrowing rate for operating leases, allowances for credit losses for available-for-sale debt securities and accounts receivable, estimates related to revenue recognition, including the assessment of performance obligations within a contract and the determination of standalone selling price (“SSP”) for each performance obligation, assumptions used to measure stock-based compensation, the fair value of private placement warrant liabilities, the fair value of assets acquired and liabilities assumed from business combinations, the fair value of contingent consideration for business combinations, the impairment of long-lived assets and goodwill, the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions, and contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, due to the inherent uncertainties in making estimates, actual results could differ from those estimates and such differences may be material. Due to current geopolitical events, including the war in Ukraine and the Israel-Hamas conflict, there is ongoing uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities. These estimates and assumptions may change in the future, as new events occur, and additional information is obtained. Segments Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. See Note 3, Revenue , for revenue by geographic region. See Note 5, Balance Sheet Components , for long-lived assets by geographic region. Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. By their nature, all such financial instruments involve risks, including the credit risk of nonperformance by counterparties. The Company’s cash, cash equivalents and short-term investments are deposited with or held by financial institutions in the U.S., Canada, Germany, the Netherlands, Slovenia, Austria, and Singapore. The Company generally does not require collateral to support the obligations of the counterparties and deposits at financial institutions may, at times, be in excess of federal or national insured limits or deposit-guarantee limits in each of the respective countries. The Company has not experienced material losses on its deposits. The maximum amount of loss at April 30, 2024 that the Company would incur if parties to cash, cash equivalents, and short-term investments failed completely to perform according to the terms of the contracts is $273.7 million. Accounts receivable are typically unsecured and are derived from revenue earned from customers across various countries. As of April 30, 2024 and January 31, 2024, no customer accounted for 10% or more of accounts receivable. For the three months ended April 30, 2024, one customer accounted for 18% of revenue. For the three months ended April 30, 2023, one customer accounted for 21% of revenue. The Company’s offerings depend on continued and new approvals from the Federal Communications Commission (“FCC”), National Oceanic and Atmospheric Administration (“NOAA”), and other U.S. and international regulatory agencies for the Company to continue its operations. There can be no assurance that the Company’s operations will continue to receive the necessary approvals or that such operations will be supported by the U.S. government or other governments. If the Company was denied such approvals, if such approvals were delayed, or if the U.S. government’s or other governments’ policies change, these events may have a material adverse impact on the Company’s financial position and results of operations. Significant Accounting Policies The Company’s significant accounting policies are included in Note 2 of its Consolidated Financial Statements included in the 2024 Form 10-K. Recent Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (“Topic 280”): Improvements to Reportable Segment Disclosures , which clarifies that entities with a single reportable segment are subject to both new and existing segment reporting requirements under ASC 280, and modifies certain segment disclosure requirements. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (“Topic 740”): Improvements to Income Tax Disclosures , to enhance the transparency and decision usefulness of income tax disclosures, primarily through changes around the effective tax rate reconciliation and income taxes paid information. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.

Revenue

Revenue	3 Months Ended
	Apr. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Deferred Revenue During the three months ended April 30, 2024 and 2023, the Company recognized revenue of $26.2 million and $25.1 million, respectively, that had been included in deferred revenue as of January 31, 2024 and January 31, 2023, respectively. Remaining Performance Obligations The Company often enters into multi-year imagery licensing arrangements with its customers, whereby the Company generally invoices the amount for the first year of the contract at signing followed by subsequent annual invoices. Remaining performance obligations represent the amount of contracted future revenue that has not yet been recognized, which includes both deferred revenue and non-cancelable contracted revenue that will be invoiced and recognized in revenue in future periods. The Company’s remaining performance obligations were $124.9 million as of April 30, 2024, which consists of both deferred revenue of $76.9 million and non-cancelable contracted revenue that will be invoiced in future periods of $48.0 million. The Company expects to recognize approximately 81% of the remaining performance obligation over the next 12 months, approximately 98% of the remaining obligation over the next 24 months, and the remainder thereafter. Remaining performance obligations do not include unexercised contract options, written orders where funding has not been appropriated and contracts which provide the customer with a right to terminate for convenience without incurring a substantive termination penalty. Disaggregation of Revenue The following table disaggregates revenue by major geographic region: Three Months Ended April 30, (in thousands) 2024 2023 United States $ 29,060 $ 23,127 Rest of world 31,380 29,576 Total revenue $ 60,440 $ 52,703 No single country other than the U.S. accounted for more than 10% of revenue for the three months ended April 30, 2024 and 2023. Costs to Obtain and Fulfill a Contract Commissions paid to the Company’s direct sales force are considered incremental costs of obtaining a contract with a customer. Accordingly, commissions are capitalized when incurred and amortized to sales and marketing expense over the period of benefit from the underlying contracts. The period of benefit from the underlying contract is consistent with the timing of transfer to the performance obligations to which the capitalized costs relate, and is generally consistent with the contract term. During the three months ended April 30, 2024 and 2023, the Company deferred $0.3 million and $0.2 million of commission expenditures to be amortized in future periods, respectively. The Company’s amortization of commission expenditures was $0.7 million and $0.6 million for the three month periods ended April 30, 2024 and 2023, respectively. As of April 30, 2024 and January 31, 2024, deferred commissions consisted of the following: (in thousands) April 30, 2024 January 31, 2024 Deferred commission, current $ 2,104 $ 2,296 Deferred commission, non-current 1,348 1,578 Total deferred commission $ 3,452 $ 3,874 The current portion of deferred commissions are included in prepaid expenses and other current assets on the condensed consolidated balance sheets. The non-current portion of deferred commissions are included in other non-current assets on the condensed consolidated balance sheets.

Fair Value of Financial Assets

Fair Value of Financial Assets and Liabilities	3 Months Ended
	Apr. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value of Financial Assets and Liabilities	Fair Value of Financial Assets and Liabilities Assets and liabilities recognized or disclosed at fair value in the financial statements are categorized based upon the level of judgment associated with the inputs used to measure their respective fair values. The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis for recognition or disclosure purposes as of April 30, 2024 and January 31, 2024 by level within the fair value hierarchy. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and considers factors specific to the asset or liability. April 30, 2024 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: Money market funds $ 44,604 $ — $ — Restricted cash equivalents: money market funds 16,895 — — Short-term investments: U.S. Treasury securities 40,075 — — Commercial paper — 9,777 — Corporate bonds — 109,005 — U.S. government agency securities — 4,848 — Certificates of deposit — 4,513 — Total assets $ 101,574 $ 128,143 $ — Liabilities Public Warrants $ 897 $ — $ — Private Placement Warrants — — 534 Contingent consideration for acquisitions — — 12,610 Total liabilities $ 897 $ — $ 13,144 January 31, 2024 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: Money market funds $ 28,722 $ — $ — Restricted cash equivalents: money market funds 17,301 — — Short-term investments: U.S. Treasury securities 46,211 — — Commercial paper — 11,126 — Corporate bonds — 144,340 — U.S. government agency securities — 9,933 — Certificates of deposit — 3,431 — Total assets $ 92,234 $ 168,830 $ — Liabilities Public Warrants $ 1,656 $ — $ — Private Placement Warrants — — 1,305 Contingent consideration for acquisitions — — 12,891 Total liabilities $ 1,656 $ — $ 14,196 The fair value of cash held in banks and accrued and other current liabilities approximate the stated carrying value due to the short time to maturity and are excluded from the tables above. Money Market Funds The fair value of the Company’s money market funds is based on quoted active market prices for the funds and is determined using the market approach. There were no realized or unrealized gains or losses on money market funds for the three months ended April 30, 2024 and 2023. Short-term Investments The fair value of the Company’s short-term investments classified within Level 2 are valued using third-party pricing services. The pricing services utilize industry standard valuation models. Inputs utilized include market pricing based on real-time trade data for the same or similar securities and other significant inputs derived from or corroborated by observable market data. Public and Private Placement Warrants The Public Warrants are classified within Level 1 as they are publicly traded and had an observable market price in an active market. The Private Placement Warrants (excluding the Private Placement Vesting Warrants) were valued based on a Black-Scholes option pricing model. Due to the market condition vesting requirements, the fair value of the Private Placement Vesting Warrants were valued using a model based on multiple stock price paths developed through the use of a Monte Carlo simulation that incorporates into the valuation the possibility that the market condition targets may not be satisfied. The Private Placement Warrants were collectively classified as a Level 3 measurement within the fair value hierarchy because these valuation models involve the use of unobservable inputs relating to the Company’s estimate of its expected stock volatility which was developed based on the historical volatility of a publicly traded set of peer companies. The expected volatility input utilized for the fair value measurements of the Private Placement Warrants as of April 30, 2024 and January 31, 2024 was 70.0%. Contingent Consideration for Acquisitions The Company has recorded contingent consideration liabilities in connection with its acquisitions of Salo Sciences and Sinergise (see Note 6 of the Company’s Consolidated Financial Statements included in the 2024 Form 10-K). The Company measures the fair value of the contingent consideration liabilities based on significant inputs not observable in the market, which caused them to be classified as a Level 3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability for the Salo Sciences technical milestone payments is determined based on the present value of the probability-weighted payments for each of the milestones. The significant unobservable inputs used in the fair value measurement are management’s estimate of the probability to achieve the technical milestone criteria and the discount rate. The fair value of the contingent consideration liability for the Salo Sciences customer contract earnout payments is determined using a Monte Carlo simulation. The fair value estimate involves a simulation of future customer contract cash collections during the four-year performance period, the probability of entering into contracts with the named customers and discounting the probability-weighed earnout payments to present value. The significant unobservable inputs used in the fair value measurement are management’s estimate of obtaining the customer contracts, including probabilities, timing and contract values, and management’s estimate of the discount rate. The fair value of the contingent consideration liability for the Sinergise customer consent escrow is determined based on the present value of the probability-weighted payments based on the likelihood of the customer consent being achieved. The significant unobservable input used in the fair value measurement is management’s estimate of the likelihood of the customer consent being achieved. Level 3 Disclosures The following is a roll-forward of Level 3 liabilities measured at fair value for the three months ended April 30, 2024 and 2023: (in thousands) Private Placement Warrants Technical Milestone Contingent Consideration* Customer Contract Earnout Contingent Consideration* Customer Consent Escrow Contingent Consideration* Fair value at end of year, January 31, 2023 $ 9,701 $ 4,433 $ 3,597 $ — Change in fair value (3,323) 5 (428) — Fair value at April 30, 2023 $ 6,378 $ 4,438 $ 3,169 $ — Fair value at end of year, January 31, 2024 $ 1,305 $ 5,114 $ 1,926 $ 5,851 Payments — — (180) — Change in fair value (771) (183) 13 69 Fair value at April 30, 2024 $ 534 $ 4,931 $ 1,759 $ 5,920 * The current portion of the contingent consideration liabilities balances of $9.7 million and $7.0 million as of April 30, 2024 and January 31, 2024, respectively, are included within accrued and other current liabilities. Changes in fair value of the contingent consideration liability for the Salo Sciences technical milestone payments are included within research and development expenses. Changes in fair value of the Salo Sciences contingent consideration liability for customer contract earnout payments are included within sales and marketing expenses. Changes in fair value of the contingent consideration liability for the Sinergise acquisition escrow payments are included within general and administrative expenses. Other

Balance Sheet Components

Balance Sheet Components	3 Months Ended
	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Cash and Cash Equivalents, and Restricted Cash and Cash Equivalents Cash and cash equivalents include interest-bearing bank deposits, money market funds and other highly liquid investments with maturities of 90 days or less at the date of purchase. The Company had restricted cash and cash equivalents balances of $18.4 million and $18.3 million as of April 30, 2024 and January 31, 2024, respectively. The restricted cash and cash equivalents balances as of April 30, 2024 and January 31, 2024 primarily consisted of $12.5 million of consideration placed in escrow in connection with the Sinergise acquisition and $4.0 million of collateral money market investments for the Company’s headquarters and other domestic office operating leases. A reconciliation of the Company’s cash and cash equivalents and restricted cash and cash equivalents in the condensed consolidated balance sheets to total cash and cash equivalents, and restricted cash and cash equivalents in the condensed consolidated statements of cash flows as of April 30, 2024 and January 31, 2024 is as follows: (in thousands) April 30, 2024 January 31, 2024 Cash and cash equivalents $ 107,367 $ 83,866 Restricted cash and cash equivalents, current 8,802 8,360 Restricted cash and cash equivalents, non-current 9,564 9,972 Total cash, cash equivalents, and restricted cash and cash equivalents $ 125,733 $ 102,198 Short-term Investments Short-term investments consisted of the following as of April 30, 2024 and January 31, 2024: April 30, 2024 Gross Unrealized (in thousands) Cost or Amortized Cost Gains Losses Fair Value U.S Treasury securities $ 40,239 $ — $ (164) $ 40,075 Commercial paper 9,777 — — 9,777 Corporate bonds 109,082 78 (154) 109,006 U.S. government agency securities 4,868 — (21) 4,847 Certificates of deposit 4,513 — — 4,513 Total short-term investments $ 168,479 $ 78 $ (339) $ 168,218 January 31, 2024 Gross Unrealized (in thousands) Cost or Amortized Cost Gains Losses Fair Value U.S Treasury securities $ 46,185 $ 118 $ (92) $ 46,211 Commercial paper 11,126 — — 11,126 Corporate bonds 144,119 376 (155) 144,340 U.S. government agency securities 9,928 17 (13) 9,932 Certificates of deposit 3,432 — — 3,432 Total short-term investments $ 214,790 $ 511 $ (260) $ 215,041 The following table summarizes the contracted maturities of the Company’s short-term investments as of April 30, 2024 and January 31, 2024: April 30, 2024 January 31, 2024 (in thousands) Amortized Cost Fair Value Amortized Cost Fair Value Due in 1 year or less $ 118,836 $ 118,697 $ 148,396 $ 148,296 Due in 1-2 years 49,643 49,521 66,394 66,745 $ 168,479 $ 168,218 $ 214,790 $ 215,041 Property and Equipment, Net Property and equipment, net consists of the following: (in thousands) April 30, 2024 January 31, 2024 Satellites $ 277,963 $ 300,203 Satellites in process and not placed into service 38,873 32,468 Leasehold improvements 17,086 17,089 Ground stations and ground station equipment 19,889 19,098 Office furniture, equipment and fixtures 9,025 8,044 Computer equipment and purchased software 9,494 9,446 Total property and equipment, gross 372,330 386,348 Less: Accumulated depreciation (260,992) (272,919) Total property and equipment, net $ 111,338 $ 113,429 The Company’s long-lived assets by geographic region are as follows: (in thousands) April 30, 2024 January 31, 2024 United States $ 104,941 $ 107,070 Rest of world 6,397 6,359 Total property and equipment, net $ 111,338 $ 113,429 The Company concluded that satellites in service continue to be owned by the U.S. entity and accordingly are classified as U.S. assets in the table above. No single country other than the U.S. accounted for more than 10% of total property and equipment, net, as of April 30, 2024 and January 31, 2024. Total depreciation expense for the three months ended April 30, 2024 and 2023 was $11.0 million and $8.7 million, respectively, of which $10.3 million and $8.2 million, respectively, was depreciation expense specific to satellites. Capitalized Internal-Use Software Development Costs Capitalized internal-use software costs, net of accumulated amortization consists of the following: (in thousands) April 30, 2024 January 31, 2024 Capitalized internal-use software $ 46,704 $ 45,010 Less: Accumulated amortization (30,638) (30,037) Capitalized internal-use software, net $ 16,066 $ 14,973 Amortization expense for capitalized internal-use software for the three months ended April 30, 2024 and 2023 was $0.6 million and $0.5 million, respectively. Goodwill and Intangible Assets Goodwill and Intangible assets consist of the following: April 30, 2024 January 31, 2024 (in thousands) Gross Accumulated Foreign Net Gross Accumulated Foreign Net Developed technology $ 30,430 $ (11,785) $ (331) $ 18,314 $ 30,429 $ (11,085) $ (220) $ 19,124 Image library 19,500 (12,237) 282 7,545 19,324 (11,852) 218 7,690 Customer relationships 7,143 (3,912) (80) 3,151 7,143 (3,715) (42) 3,386 Trade names and other 6,389 (4,026) 30 2,393 6,089 (3,877) 36 2,248 Total intangible assets $ 63,462 $ (31,960) $ (99) $ 31,403 $ 62,985 $ (30,529) $ (8) $ 32,448 Goodwill $ 135,981 $ — $ 1,129 $ 137,110 $ 134,914 $ — $ 1,342 $ 136,256 Amortization expense for intangible assets for the three months ended April 30, 2024 and 2023 was $1.5 million and $1.1 million, respectively. The change in the carrying amount of goodwill during the three months ended April 30, 2024 and 2023 is as follows: Three Months Ended April 30, (in thousands) 2024 2023 Beginning of period $ 136,256 $ 112,748 Addition 1,068 — Currency translation adjustment (214) — End of period $ 137,110 $ 112,748 During the three months ended April 30, 2024, the Company paid $1.1 million of additional consideration in connection with the finalization of the net working capital adjustment relating to the Company’s acquisition of Sinergise. The acquisition of Sinergise was completed on August 4, 2023. The additional amount was accounted for as a measurement period adjustment and resulted in a $1.1 million addition of goodwill during the three months ended April 30, 2024. Accrued and Other Current Liabilities Accrued liabilities and other current liabilities consist of the following: (in thousands) April 30, 2024 January 31, 2024 Deferred R&D service liability (see Note 7) $ 8,034 $ 9,923 Payroll and related expenses 5,208 6,882 Deferred hosting costs 5,053 5,007 Withholding taxes and other taxes payable 1,898 3,152 Contingent consideration 9,695 7,006 Other accruals 13,473 12,809 Total accrued and other current liabilities $ 43,361 $ 44,779

Leases

Leases	3 Months Ended
	Apr. 30, 2024
Leases [Abstract]
Leases	Leases The Company’s leasing activities primarily consist of real estate leases for its operations, including office space, and certain ground station service agreements that convey the right to control the use of specified equipment and facilities. The Company assesses whether each lease is an operating or finance lease at the lease commencement date. As of April 30, 2024, the Company has no finance leases. Operating lease costs were $2.3 million and $2.0 million for the three months ended April 30, 2024 and 2023, respectively. Variable lease expenses and short-term lease expenses were immaterial for the three months ended April 30, 2024 and 2023. Operating cash flows from operating leases were $2.4 million and $1.1 million for the three months ended April 30, 2024 and 2023, respectively. Right of use assets obtained in exchange for operating lease liabilities were $0.5 million and $4.8 million for the three months ended April 30, 2024 and 2023, respectively. Maturities of operating lease liabilities as of April 30, 2024 were as follows: (in thousands) Remainder of Fiscal Year 2025 $ 7,268 2026 9,335 2027 6,208 2028 2,042 2029 936 Thereafter 457 Total lease payments $ 26,246 Less: Imputed interest (2,864) Total lease liabilities $ 23,382 Weighted average remaining lease term (years) 3.0 Weighted average discount rate 8.1 %

Research and Development Arrang

Research and Development Arrangements	3 Months Ended
	Apr. 30, 2024
Research and Development [Abstract]
Research and Development Arrangements	Research and Development Arrangements Research and Development Services Agreement In December 2020, the Company entered into a development services agreement whereby the Company agreed to provide the technical knowledge and services to design and develop certain prototype satellites and deliver and test early data collected (the “ R&D Services Agreement ”). The R&D Services Agreement, including subsequent amendments to such agreement, provides for funding of $45.8 million to be paid to the Company as specified milestones are achieved. The R&D Services Agreement is unrelated to the Company’s ordinary business activities. The Company has discretion in managing the activities under the R&D Services Agreement and retains all developed intellectual property. The Company has no obligation to repay any of the funds received regardless of the outcome of the development work; therefore, the arrangement is accounted for as funded research and development pursuant to ASC 730-20, Research and Development . As ASC 730-20 does not indicate the accounting model for research and development services, the Company determined the total transaction price is recognized over the agreement term as a reduction of research and development expenses based on a cost incurred method. During the three months ended April 30, 2024 and 2023, the Company recognized $3.2 million and $4.0 million of funding and incurred $2.3 million and $4.0 million of research and development expenses, respectively, in connection with the R&D Services Agreement. As of April 30, 2024 and January 31, 2024, the Company had received a total of $45.8 million of funding under the R&D Services Agreement. NASA Communication Services Project In connection with its Communication Services Project (“CSP”), the National Aeronautics and Space Administration (“NASA”) selected certain satellite communications providers that NASA will fund to develop and demonstrate near-Earth space communication services that may support future NASA missions using commercial technology. In June 2022 and August 2022, the Company entered into separate agreements with two of the satellite communications providers selected by NASA whereby the Company agreed to participate in the NASA CSP as a subcontractor. The agreements provide for the Company to receive aggregate funding of $40.5 million to be paid as milestones are completed. The Company determined that the agreements are in the scope of ASC 912-730, Contractors –Federal Government – Research and Development (“ASC 912-730”). In accordance with ASC 912-730, funding is recognized over the term of each agreement as a reduction of research and development expenses based on a cost incurred method. During the three months ended April 30, 2024 and 2023, the Company recognized $2.6 million and $3.1 million of funding, respectively, and incurred $2.7 million and $3.9 million

Commitment and Contingencies

Commitment and Contingencies	3 Months Ended
	Apr. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Other The Company has minimum purchase commitments for hosting services from Google through January 31, 2028 (see Note 10). Future minimum purchase commitments under the noncancelable hosting service agreement with Google as of April 30, 2024 are as follows: (in thousands) Remainder of Fiscal Year 2025 $ 26,030 2026 31,190 2027 32,725 2028 33,427 Total purchase commitments $ 123,372 Contingencies The Company is not a party to any material legal proceedings and is not aware of any pending or threatened claims, individually or in the aggregate, that are expected to have a material adverse impact on its condensed consolidated financial statements as of each reporting period. From time to time however, the Company may have certain contingent liabilities that arise in the ordinary course of business activities including those arising from disputes and claims and events arising from revenue contracts entered into by the Company. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. Indemnification The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent, or other intellectual property infringement claim by any third-party with respect to its technology. The term of these indemnification agreements is generally perpetual after the execution of the agreement. The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. In the event that one or more of these matters were to result in a claim against the Company, an adverse outcome, including a judgment or settlement, may cause a material adverse effect on the Company’s future business, operating results or financial condition. It is not possible to determine the maximum potential amount under these contracts due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify them against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. To date, we have not incurred any material costs, and have not accrued any liabilities in the consolidated financial statements as a result of these provisions.

Warrants

Warrants	3 Months Ended
	Apr. 30, 2024
Warrants [Abstract]
Warrants	Warrants Public and Private Placement Warrants In connection with dMY IV’s initial public offering, which occurred on March 9, 2021, dMY IV issued 34,500,000 units, each unit consisting of one share of Class A common stock of dMY IV and one-fifth of one redeemable warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (the “Public Warrants”). Simultaneously with the closing of its initial public offering, dMY IV completed the private sale of 5,933,333 warrants to dMY Sponsor IV, LLC (the “dMY Sponsor”) at a purchase price of $1.50 per warrant (the “Private Placement Warrants”). Each Private Placement Warrant is exercisable for one share of Class A common stock at $11.50 per share. Additionally, pursuant to a lock-up agreement entered into with the dMY Sponsor in connection with the Business Combination, 2,966,667 of the Private Placement Warrants are subject to vesting conditions (the “Private Placement Vesting Warrants”). The Private Placement Vesting Warrants vest in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00. Any right to Private Placement Vesting Warrants that remains unvested on the first business day after five years from the closing of the Business Combination will be forfeited without any further consideration. As of April 30, 2024 and January 31, 2024, there were 6,899,982 Public Warrants and 5,933,333 Private Placement Warrants, including 2,966,667 Private Placement Vesting Warrants, outstanding. Warrants to Purchase Class A Common Stock In addition to the Public and Private Placement Warrants, there were 1,065,594 warrants to purchase shares of Class A common stock with a weighted average exercise price of $9.384 which were outstanding and exercisable as of April 30, 2024 and January 31, 2024. As of April 30, 2024, the outstanding warrants have a weighted average remaining term of 5.9 years.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Apr. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions As of April 30, 2024 and January 31, 2024, Google held 31,942,641 shares of the Company’s Class A common stock, and, as such, owned greater than 10% of outstanding shares of the Company’s Class A common stock. In April 2017, the Company and Google entered into a five year content license agreement pursuant to which the Company licensed content to Google. In April 2022, the agreement automatically renewed for a period of one year and, in April 2023, the agreement expired. For the three months ended April 30, 2023, the Company recognized revenue of $0.3 million related to the content license agreement. In July 2023, the Company and Google entered into a one year content license agreement pursuant to which the Company agreed to license content to Google and provide certain of its products in exchange for a $1.0 million fee. The agreement also provides for the Company to receive up to $2.0 million in value of Google cloud credits that the Company can apply against the cost of Google cloud services it utilizes to fulfill its obligations under the agreement. The Company determined that the Google cloud credits represent non-cash variable consideration which is included in the transaction price for the agreement, subject to the guidance on estimating variable consideration within ASC 606, Revenue from Contracts with Customers . The agreement does not include extension or renewal terms. For the three months ended April 30, 2024, the Company recognized immaterial revenue related to the content license agreement. T he Company purchases hosting and other services from Google, of which $14.3 million and $12.1 million is deferred as of April 30, 2024 and January 31, 2024 , respectively. The Company recorded $7.0 million of expense during the three months ended April 30, 2024 relating to hosting and other services provided by Google, of which $6.3 million was classified as cost of revenue and $0.7 million was classified as research and development. The Company recorded $6.4 million of expense during the three months ended April 30, 2023 related to hosting and other services provided by Google, of which $5.8 million was classified as cost of revenue and $0.6 million was classified as research and development. As of April 30, 2024 and January 31, 2024 , the Company’s accrued and other current liabilities balance included $2.5 million related to hosting and other services provided by Google. On June 28, 2021,

Stock-based Compensation

Stock-based Compensation	3 Months Ended
	Apr. 30, 2024
Share-Based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation The Company's equity incentive plans are described in Note 16, Stock-based Compensation , in the Notes to the Consolidated Financial Statements in the 2024 Form 10-K. Stock-Based Compensation The following table summarizes stock-based compensation expense recognized related to awards granted to employees and nonemployees, as follows: Three Months Ended April 30, (in thousands) 2024 2023 Cost of revenue $ 981 $ 917 Research and development 5,731 6,585 Sales and marketing 2,403 3,080 General and administrative 4,630 5,401 Total expense 13,745 15,983 Capitalized to internal-use software development costs and property and equipment (673) (627) Total stock-based compensation expense $ 13,072 $ 15,356 Stock Options A summary of stock option activity is as follows: Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Term (Years) Aggregate Intrinsic Value (in thousands) Balances at January 31, 2024 26,956,953 $ 5.34 5.7 Exercised (35,318) $ 0.56 Granted — $ — Forfeited (99,529) $ 4.63 Balances at April 30, 2024 26,822,106 $ 5.35 5.5 $ 200 Vested and exercisable at April 30, 2024 23,867,411 $ 4.90 5.3 $ 200 As of April 30, 2024, total unrecognized compensation cost related to stock options was $12.5 million which is expected to be recognized over a period of 1.3 years . Restricted Stock Units A summary of Restricted Stock Unit (“RSU”) activity is as follows: Number of RSUs Weighted Average Grant Date Fair Value Balances at January 31, 2024 26,718,766 $ 4.45 Vested (2,201,472) $ 4.92 Granted 23,425,602 $ 2.36 Forfeited (929,481) $ 3.81 Balances at April 30, 2024 47,013,415 $ 3.40 During the three months ended April 30, 2024, the Company granted 23,425,602 RSUs, which generally vest over four years, subject to the recipient’s continued service through each applicable vesting date. Stock-based compensation expense recognized for RSUs during the three months ended April 30, 2024 and 2023 was $10.8 million and $9.4 million, respectively. As of April 30, 2024, total unrecognized compensation cost related to RSUs was $139.9 million. These costs are expected to be recognized over a period of approximately 3.2 years . Performance Vesting Restricted Stock Units During the three months ended April 30, 2024, the Company granted 348,222 performance vesting restricted stock units (“PSUs”) to certain members of the Company’s senior management. A portion of the PSUs are subject to vesting requirements related to the achievement of certain revenue and adjusted EBITDA targets for the first half of the fiscal year ended January 31, 2025 and the remaining portion is subject to vesting requirements related to the achievement of certain revenue and adjusted EBITDA targets for the entire fiscal year ended January 31, 2025. Vesting is also subject to continued service through the applicable vesting dates and the actual number of PSUs that may vest ranges from 0% to 125% of the PSUs granted based on achievement of the targets. During the three months ended April 30, 2024, the Company recognized $0.2 million of stock-based compensation expense related to PSUs. Stock-based compensation expense recognized for PSUs during the three months ended April 30, 2023 was immaterial. As of April 30, 2024, total unrecognized compensation cost related to PSUs was $0.8 million. These costs are expected to be recognized over a period of approximately 0.9 years. Employee Stock Purchase Program Beginning in April 2024, the Company's eligible employees were able to begin participating in the Company's Employee Stock Purchase Program (“ESPP”). The ESPP allows eligible participants to contribute up to 10% of their eligible compensation towards the purchase of Class A common stock at a discounted price, subject to certain limitations. The purchase price of the shares on each purchase date is equal to 85% of the lower of the fair market value of Class A common stock on the first and last trading days of each offering period. The offerings under the ESPP are currently designed to be intended to qualify under Section 423 of the Internal Revenue Code. The Company estimates the fair value of each purchase right under the ESPP on the date of grant using the Black-Scholes valuation model and uses the straight-line attribution approach to record the expense over the six-month offering period. During the three months ended April 30, 2024, the Company recognized $0.1 million of stock-based compensation expense related to the ESPP. As of April 30, 2024, total unrecognized compensation cost related to ESPP was $0.3 million. These costs are expected to be recognized over a period of approximately 0.4 years Early Exercises of Stock Options The Planet Labs Inc. Amended and Restated 2011 Stock Incentive Plan provided for the early exercise of stock options for certain individuals as determined by the Company’s board of directors. Shares of common stock issued upon early exercises of unvested options are not deemed, for accounting purposes, to be issued until those shares vest according to their respective vesting schedules and accordingly, the consideration received for early exercises is initially recorded as a liability and reclassified to common stock and additional paid-in capital as the underlying awards vest. As of April 30, 2024, the Company had a $8.1 million liability recorded for the early exercise of unvested stock options, and the related number of unvested shares subject to repurchase was 827,190. Earn-out Shares Pursuant to the Merger Agreement, Former Planet equity award holders have the right to receive Earn-out Shares that are contingently issuable in shares of Class A common stock. The Earn-out Shares may be earned in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00. No Earn-out Shares vested during the three months ended April 30, 2024 or 2023. As of April 30, 2024, there were 3,579,424 Earn-out Shares outstanding relating to Former Planet equity award holders. As of April 30, 2024 and January 31, 2024, there was no unrecognized compensation cost related to the Earn-out Shares. During the three months ended April 30, 2023, the Company recognized $2.3 million of stock-based compensation expense related to the Earn-out Shares. Other Stock-based Compensation In connection with the acquisition of VanderSat B.V. (“VanderSat”) on December 13, 2021, the Company issued 543,391 shares of Class A common stock to an employee and former owner of VanderSat which are accounted for as stock-based compensation because the shares were subject to forfeiture based on post-acquisition time-based service vesting. The shares vested in quarterly increments over two years commencing on December 13, 2021. As of April 30, 2024 and January 31, 2024, there was no unrecognized compensation cost related to these shares. During the three months ended April 30, 2023, the Company recognized $0.6 million of stock-based compensation expense related to these shares.

Income Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company recorded income tax expense of $0.4 million and $0.3 million for the three months ended April 30, 2024 and 2023, respectively. For the three months ended April 30, 2024 and 2023, the income tax expense was primarily driven by the current tax on foreign earnings. The effective tax rates for the three months ended April 30, 2024 and 2023 differed from the federal statutory tax rate primarily due to the valuation allowance on the majority of the Company’s U.S. and foreign deferred tax assets and foreign rate differences. The Company evaluates its tax positions on a quarterly basis and revises its estimates accordingly. Gross unrecognized tax benefits were $9.1 million and $8.7 million as of April 30, 2024 and January 31, 2024, respectively. The gross unrecognized tax benefits, if recognized, would not affect the effective tax rate due to the valuation allowance against the deferred tax assets. The Company determined that no accrual for interest and penalties was required as of April 30, 2024 and January 31, 2024 and no such expenses were incurred in the periods presented. The Company does not anticipate the total amounts of unrecognized tax benefits to significantly increase or decrease in the next twelve months. The Company files U.S. federal, various state and foreign income tax returns. The Company is not currently under audit by any taxing authorities. All tax years remain open to examination by taxing jurisdictions to which the Company is subject.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	3 Months Ended
	Apr. 30, 2024
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The Company computes net loss per share of the Class A common stock and Class B common stock using the two-class method required for participating securities. Basic and diluted net loss per share are the same for each class of common stock because they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted loss per Class A common stock and Class B common stock (amounts in thousands, except share and per share amounts): Three Months Ended April 30, 2024 2023 Numerator: Net loss attributable to common stockholders $ (29,293) $ (34,444) Denominator: Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders 288,268,718 272,347,977 Basic and diluted net loss per share attributable to common stockholders $ (0.10) $ (0.13) Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential Class A common stock and Class B common stock outstanding would have been anti-dilutive. The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: As of April 30, 2024 2023 Warrants to purchase Class A common stock 1,065,594 1,065,594 Common stock options 26,822,106 32,152,247 Restricted Stock Units 47,013,415 31,095,675 Performance vesting Restricted Stock Units 355,372 — Shares committed under ESPP 120,204 — Earn-out Shares 25,038,434 25,567,385 dMY Sponsor Earn-out Shares 862,500 862,500 Public Warrants 6,899,982 6,899,982 Private Placement Warrants 5,933,333 5,933,333 Early exercised common stock options, subject to future vesting 827,190 1,194,830 Shares issued in connection with acquisition, subject to future vesting — 203,771 Total 114,938,130 104,975,317

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Pay vs Performance Disclosure
Net loss	$ (29,293)	$ (34,444)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Apr. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements are unaudited; however, in the opinion of management they include all normal and recurring adjustments necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements for the periods presented. Operating results for the three months ended April 30, 2024 are not necessarily indicative of the results expected for the fiscal year ending January 31, 2025 or any other future period. The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and include the accounts of Planet Labs PBC and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year end is January 31.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant estimates and assumptions that affect the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the useful lives of property and equipment, capitalized internal-use software and intangible assets, the Company’s incremental borrowing rate for operating leases, allowances for credit losses for available-for-sale debt securities and accounts receivable, estimates related to revenue recognition, including the assessment of performance obligations within a contract and the determination of standalone selling price (“SSP”) for each performance obligation, assumptions used to measure stock-based compensation, the fair value of private placement warrant liabilities, the fair value of assets acquired and liabilities assumed from business combinations, the fair value of contingent consideration for business combinations, the impairment of long-lived assets and goodwill, the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions, and contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, due to the inherent uncertainties in making estimates, actual results could differ from those estimates and such differences may be material. Due to current geopolitical events, including the war in Ukraine and the Israel-Hamas conflict, there is ongoing uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities. These estimates and assumptions may change in the future, as new events occur, and additional information is obtained.
Segments	Segments
Concentration of Credit Risk and Other Risks and Uncertainties	Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. By their nature, all such financial instruments involve risks, including the credit risk of nonperformance by counterparties. The Company’s cash, cash equivalents and short-term investments are deposited with or held by financial institutions in the U.S., Canada, Germany, the Netherlands, Slovenia, Austria, and Singapore. The Company generally does not require collateral to support the obligations of the counterparties and deposits at financial institutions may, at times, be in excess of federal or national insured limits or deposit-guarantee limits in each of the respective countries. The Company has not experienced material losses on its deposits. The maximum amount of loss at April 30, 2024 that the Company would incur if parties to cash, cash equivalents, and short-term investments failed completely to perform according to the terms of the contracts is $273.7 million. Accounts receivable are typically unsecured and are derived from revenue earned from customers across various countries. As of April 30, 2024 and January 31, 2024, no customer accounted for 10% or more of accounts receivable. For the three months ended April 30, 2024, one customer accounted for 18% of revenue. For the three months ended April 30, 2023, one customer accounted for 21% of revenue.
Recent Pronouncements Not Yet Adopted	Recent Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (“Topic 280”): Improvements to Reportable Segment Disclosures , which clarifies that entities with a single reportable segment are subject to both new and existing segment reporting requirements under ASC 280, and modifies certain segment disclosure requirements. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (“Topic 740”): Improvements to Income Tax Disclosures , to enhance the transparency and decision usefulness of income tax disclosures, primarily through changes around the effective tax rate reconciliation and income taxes paid information. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Apr. 30, 2024
Revenue from Contract with Customer [Abstract]
Schedule Of Disaggregation of Revenue	The following table disaggregates revenue by major geographic region: Three Months Ended April 30, (in thousands) 2024 2023 United States $ 29,060 $ 23,127 Rest of world 31,380 29,576 Total revenue $ 60,440 $ 52,703
Schedule of Deferred Commissions	As of April 30, 2024 and January 31, 2024, deferred commissions consisted of the following: (in thousands) April 30, 2024 January 31, 2024 Deferred commission, current $ 2,104 $ 2,296 Deferred commission, non-current 1,348 1,578 Total deferred commission $ 3,452 $ 3,874

Fair Value of Financial Asset_2

Fair Value of Financial Assets and Liabilities (Tables)	3 Months Ended
	Apr. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and considers factors specific to the asset or liability. April 30, 2024 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: Money market funds $ 44,604 $ — $ — Restricted cash equivalents: money market funds 16,895 — — Short-term investments: U.S. Treasury securities 40,075 — — Commercial paper — 9,777 — Corporate bonds — 109,005 — U.S. government agency securities — 4,848 — Certificates of deposit — 4,513 — Total assets $ 101,574 $ 128,143 $ — Liabilities Public Warrants $ 897 $ — $ — Private Placement Warrants — — 534 Contingent consideration for acquisitions — — 12,610 Total liabilities $ 897 $ — $ 13,144 January 31, 2024 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: Money market funds $ 28,722 $ — $ — Restricted cash equivalents: money market funds 17,301 — — Short-term investments: U.S. Treasury securities 46,211 — — Commercial paper — 11,126 — Corporate bonds — 144,340 — U.S. government agency securities — 9,933 — Certificates of deposit — 3,431 — Total assets $ 92,234 $ 168,830 $ — Liabilities Public Warrants $ 1,656 $ — $ — Private Placement Warrants — — 1,305 Contingent consideration for acquisitions — — 12,891 Total liabilities $ 1,656 $ — $ 14,196
Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following is a roll-forward of Level 3 liabilities measured at fair value for the three months ended April 30, 2024 and 2023: (in thousands) Private Placement Warrants Technical Milestone Contingent Consideration* Customer Contract Earnout Contingent Consideration* Customer Consent Escrow Contingent Consideration* Fair value at end of year, January 31, 2023 $ 9,701 $ 4,433 $ 3,597 $ — Change in fair value (3,323) 5 (428) — Fair value at April 30, 2023 $ 6,378 $ 4,438 $ 3,169 $ — Fair value at end of year, January 31, 2024 $ 1,305 $ 5,114 $ 1,926 $ 5,851 Payments — — (180) — Change in fair value (771) (183) 13 69 Fair value at April 30, 2024 $ 534 $ 4,931 $ 1,759 $ 5,920 * The current portion of the contingent consideration liabilities balances of $9.7 million and $7.0 million as of April 30, 2024 and January 31, 2024, respectively, are included within accrued and other current liabilities. Changes in fair value of the contingent consideration liability for the Salo Sciences technical milestone payments are included within research and development expenses. Changes in fair value of the Salo Sciences contingent consideration liability for customer contract earnout payments are included within sales and marketing expenses. Changes in fair value of the contingent consideration liability for the Sinergise acquisition escrow payments are included within general and administrative expenses.

Balance Sheet Components (Table

Balance Sheet Components (Tables)	3 Months Ended
	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Cash and Cash Equivalents	A reconciliation of the Company’s cash and cash equivalents and restricted cash and cash equivalents in the condensed consolidated balance sheets to total cash and cash equivalents, and restricted cash and cash equivalents in the condensed consolidated statements of cash flows as of April 30, 2024 and January 31, 2024 is as follows: (in thousands) April 30, 2024 January 31, 2024 Cash and cash equivalents $ 107,367 $ 83,866 Restricted cash and cash equivalents, current 8,802 8,360 Restricted cash and cash equivalents, non-current 9,564 9,972 Total cash, cash equivalents, and restricted cash and cash equivalents $ 125,733 $ 102,198
Debt Securities, Available-for-Sale	Short-term investments consisted of the following as of April 30, 2024 and January 31, 2024: April 30, 2024 Gross Unrealized (in thousands) Cost or Amortized Cost Gains Losses Fair Value U.S Treasury securities $ 40,239 $ — $ (164) $ 40,075 Commercial paper 9,777 — — 9,777 Corporate bonds 109,082 78 (154) 109,006 U.S. government agency securities 4,868 — (21) 4,847 Certificates of deposit 4,513 — — 4,513 Total short-term investments $ 168,479 $ 78 $ (339) $ 168,218 January 31, 2024 Gross Unrealized (in thousands) Cost or Amortized Cost Gains Losses Fair Value U.S Treasury securities $ 46,185 $ 118 $ (92) $ 46,211 Commercial paper 11,126 — — 11,126 Corporate bonds 144,119 376 (155) 144,340 U.S. government agency securities 9,928 17 (13) 9,932 Certificates of deposit 3,432 — — 3,432 Total short-term investments $ 214,790 $ 511 $ (260) $ 215,041
Investments Classified by Contractual Maturity Date	The following table summarizes the contracted maturities of the Company’s short-term investments as of April 30, 2024 and January 31, 2024: April 30, 2024 January 31, 2024 (in thousands) Amortized Cost Fair Value Amortized Cost Fair Value Due in 1 year or less $ 118,836 $ 118,697 $ 148,396 $ 148,296 Due in 1-2 years 49,643 49,521 66,394 66,745 $ 168,479 $ 168,218 $ 214,790 $ 215,041
Schedule of Property and Equipment	Property and equipment, net consists of the following: (in thousands) April 30, 2024 January 31, 2024 Satellites $ 277,963 $ 300,203 Satellites in process and not placed into service 38,873 32,468 Leasehold improvements 17,086 17,089 Ground stations and ground station equipment 19,889 19,098 Office furniture, equipment and fixtures 9,025 8,044 Computer equipment and purchased software 9,494 9,446 Total property and equipment, gross 372,330 386,348 Less: Accumulated depreciation (260,992) (272,919) Total property and equipment, net $ 111,338 $ 113,429
Schedule of Long-lived Assets by Geographic Areas	The Company’s long-lived assets by geographic region are as follows: (in thousands) April 30, 2024 January 31, 2024 United States $ 104,941 $ 107,070 Rest of world 6,397 6,359 Total property and equipment, net $ 111,338 $ 113,429
Schedule of Capitalized Computer Software	Capitalized internal-use software costs, net of accumulated amortization consists of the following: (in thousands) April 30, 2024 January 31, 2024 Capitalized internal-use software $ 46,704 $ 45,010 Less: Accumulated amortization (30,638) (30,037) Capitalized internal-use software, net $ 16,066 $ 14,973
Schedule of Intangible Assets And Goodwill	Goodwill and Intangible assets consist of the following: April 30, 2024 January 31, 2024 (in thousands) Gross Accumulated Foreign Net Gross Accumulated Foreign Net Developed technology $ 30,430 $ (11,785) $ (331) $ 18,314 $ 30,429 $ (11,085) $ (220) $ 19,124 Image library 19,500 (12,237) 282 7,545 19,324 (11,852) 218 7,690 Customer relationships 7,143 (3,912) (80) 3,151 7,143 (3,715) (42) 3,386 Trade names and other 6,389 (4,026) 30 2,393 6,089 (3,877) 36 2,248 Total intangible assets $ 63,462 $ (31,960) $ (99) $ 31,403 $ 62,985 $ (30,529) $ (8) $ 32,448 Goodwill $ 135,981 $ — $ 1,129 $ 137,110 $ 134,914 $ — $ 1,342 $ 136,256
Schedule of Goodwill	The change in the carrying amount of goodwill during the three months ended April 30, 2024 and 2023 is as follows: Three Months Ended April 30, (in thousands) 2024 2023 Beginning of period $ 136,256 $ 112,748 Addition 1,068 — Currency translation adjustment (214) — End of period $ 137,110 $ 112,748
Schedule of Accrued Liabilities and Other Current Liabilities	Accrued liabilities and other current liabilities consist of the following: (in thousands) April 30, 2024 January 31, 2024 Deferred R&D service liability (see Note 7) $ 8,034 $ 9,923 Payroll and related expenses 5,208 6,882 Deferred hosting costs 5,053 5,007 Withholding taxes and other taxes payable 1,898 3,152 Contingent consideration 9,695 7,006 Other accruals 13,473 12,809 Total accrued and other current liabilities $ 43,361 $ 44,779

Leases (Tables)

Leases (Tables)	3 Months Ended
	Apr. 30, 2024
Leases [Abstract]
Schedule of Maturities of Operating Lease Liabilities	Maturities of operating lease liabilities as of April 30, 2024 were as follows: (in thousands) Remainder of Fiscal Year 2025 $ 7,268 2026 9,335 2027 6,208 2028 2,042 2029 936 Thereafter 457 Total lease payments $ 26,246 Less: Imputed interest (2,864) Total lease liabilities $ 23,382 Weighted average remaining lease term (years) 3.0 Weighted average discount rate 8.1 %

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	3 Months Ended
	Apr. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Other Commitments	Future minimum purchase commitments under the noncancelable hosting service agreement with Google as of April 30, 2024 are as follows: (in thousands) Remainder of Fiscal Year 2025 $ 26,030 2026 31,190 2027 32,725 2028 33,427 Total purchase commitments $ 123,372

Stock-based Compensation (Table

Stock-based Compensation (Tables)	3 Months Ended
	Apr. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-Based Compensation Expense	The following table summarizes stock-based compensation expense recognized related to awards granted to employees and nonemployees, as follows: Three Months Ended April 30, (in thousands) 2024 2023 Cost of revenue $ 981 $ 917 Research and development 5,731 6,585 Sales and marketing 2,403 3,080 General and administrative 4,630 5,401 Total expense 13,745 15,983 Capitalized to internal-use software development costs and property and equipment (673) (627) Total stock-based compensation expense $ 13,072 $ 15,356
Summary of Stock Option Activity	A summary of stock option activity is as follows: Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Term (Years) Aggregate Intrinsic Value (in thousands) Balances at January 31, 2024 26,956,953 $ 5.34 5.7 Exercised (35,318) $ 0.56 Granted — $ — Forfeited (99,529) $ 4.63 Balances at April 30, 2024 26,822,106 $ 5.35 5.5 $ 200 Vested and exercisable at April 30, 2024 23,867,411 $ 4.90 5.3 $ 200
Summary of Restricted Stock Unit ("RSU") Activity	A summary of Restricted Stock Unit (“RSU”) activity is as follows: Number of RSUs Weighted Average Grant Date Fair Value Balances at January 31, 2024 26,718,766 $ 4.45 Vested (2,201,472) $ 4.92 Granted 23,425,602 $ 2.36 Forfeited (929,481) $ 3.81 Balances at April 30, 2024 47,013,415 $ 3.40

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	3 Months Ended
	Apr. 30, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	The following table sets forth the computation of basic and diluted loss per Class A common stock and Class B common stock (amounts in thousands, except share and per share amounts): Three Months Ended April 30, 2024 2023 Numerator: Net loss attributable to common stockholders $ (29,293) $ (34,444) Denominator: Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders 288,268,718 272,347,977 Basic and diluted net loss per share attributable to common stockholders $ (0.10) $ (0.13)
Schedule of Antidilutive Securities	The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: As of April 30, 2024 2023 Warrants to purchase Class A common stock 1,065,594 1,065,594 Common stock options 26,822,106 32,152,247 Restricted Stock Units 47,013,415 31,095,675 Performance vesting Restricted Stock Units 355,372 — Shares committed under ESPP 120,204 — Earn-out Shares 25,038,434 25,567,385 dMY Sponsor Earn-out Shares 862,500 862,500 Public Warrants 6,899,982 6,899,982 Private Placement Warrants 5,933,333 5,933,333 Early exercised common stock options, subject to future vesting 827,190 1,194,830 Shares issued in connection with acquisition, subject to future vesting — 203,771 Total 114,938,130 104,975,317

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Basis of Presentation and Liquidity (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Accounting Policies [Abstract]
Cash and cash equivalents	$ 107,367	$ 83,866
Short-term investments	$ 168,218	$ 215,041

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Segments (Details)	3 Months Ended
	Apr. 30, 2024 segment
Accounting Policies [Abstract]
Number of operating segments	1
Number of reportable segments	1

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Concentration Risk [Line Items]
Concentration risk, credit risk, maximum exposure	$ 273.7
Customer Concentration Risk | Revenue Benchmark | Customer 1
Concentration Risk [Line Items]
Concentration risk	18%	21%

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Disaggregation of Revenue [Line Items]
Deferred revenue, revenue recognized	$ 26.2	$ 25.1
Remaining performance obligation, amount	124.9
Deferred revenue	76.9
Non-cancelable contract revenue	48
Deferred commission expense	0.3	0.2
Amortization of deferred commission	$ 0.7	$ 0.6
United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk	10%	10%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-05-01 | Minimum
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	81%
Remaining performance obligation, expected timing of satisfaction	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-05-01 | Maximum
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	98%
Remaining performance obligation, expected timing of satisfaction	24 months

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Disaggregation of Revenue [Line Items]
Revenue	$ 60,440	$ 52,703
United States
Disaggregation of Revenue [Line Items]
Revenue	29,060	23,127
Rest of world
Disaggregation of Revenue [Line Items]
Revenue	$ 31,380	$ 29,576

Revenue - Schedule of Deferred

Revenue - Schedule of Deferred Commissions (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Revenue from Contract with Customer [Abstract]
Deferred commission, current	$ 2,104	$ 2,296
Deferred commission, non-current	1,348	1,578
Total deferred commission	$ 3,452	$ 3,874

Fair Value of Financial Asset_3

Fair Value of Financial Assets and Liabilities - Schedule of Fair Value by Balance Sheet Location (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Assets
Short-term investments	$ 168,218	$ 215,041
Liabilities
Warrants and contingent consideration	1,431	2,961
U.S. Treasury securities
Assets
Short-term investments	40,075	46,211
Commercial paper
Assets
Short-term investments	9,777	11,126
Corporate bonds
Assets
Short-term investments	109,006	144,340
U.S. government agency securities
Assets
Short-term investments	4,847	9,932
Certificates of deposit
Assets
Short-term investments	4,513	3,432
Fair Value, Recurring | Level 1
Assets
Total assets	101,574	92,234
Liabilities
Total liabilities	897	1,656
Fair Value, Recurring | Level 1 | Public Warrants
Liabilities
Warrants and contingent consideration	897	1,656
Fair Value, Recurring | Level 1 | Private Placement Warrants
Liabilities
Warrants and contingent consideration	0	0
Fair Value, Recurring | Level 1 | Contingent consideration for acquisitions
Liabilities
Warrants and contingent consideration	0	0
Fair Value, Recurring | Level 1 | U.S. Treasury securities
Assets
Short-term investments	40,075	46,211
Fair Value, Recurring | Level 1 | Commercial paper
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 1 | Corporate bonds
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 1 | U.S. government agency securities
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 1 | Certificates of deposit
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 1 | Money market funds
Assets
Cash equivalents:	44,604	28,722
Restricted cash equivalents: money market funds	16,895	17,301
Fair Value, Recurring | Level 2
Assets
Total assets	128,143	168,830
Liabilities
Total liabilities	0	0
Fair Value, Recurring | Level 2 | Public Warrants
Liabilities
Warrants and contingent consideration	0	0
Fair Value, Recurring | Level 2 | Private Placement Warrants
Liabilities
Warrants and contingent consideration	0	0
Fair Value, Recurring | Level 2 | Contingent consideration for acquisitions
Liabilities
Warrants and contingent consideration	0	0
Fair Value, Recurring | Level 2 | U.S. Treasury securities
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 2 | Commercial paper
Assets
Short-term investments	9,777	11,126
Fair Value, Recurring | Level 2 | Corporate bonds
Assets
Short-term investments	109,005	144,340
Fair Value, Recurring | Level 2 | U.S. government agency securities
Assets
Short-term investments	4,848	9,933
Fair Value, Recurring | Level 2 | Certificates of deposit
Assets
Short-term investments	4,513	3,431
Fair Value, Recurring | Level 2 | Money market funds
Assets
Cash equivalents:	0	0
Restricted cash equivalents: money market funds	0	0
Fair Value, Recurring | Level 3
Assets
Total assets	0	0
Liabilities
Total liabilities	13,144	14,196
Fair Value, Recurring | Level 3 | Public Warrants
Liabilities
Warrants and contingent consideration	0	0
Fair Value, Recurring | Level 3 | Private Placement Warrants
Liabilities
Warrants and contingent consideration	534	1,305
Fair Value, Recurring | Level 3 | Contingent consideration for acquisitions
Liabilities
Warrants and contingent consideration	12,610	12,891
Fair Value, Recurring | Level 3 | U.S. Treasury securities
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 3 | Commercial paper
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 3 | Corporate bonds
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 3 | U.S. government agency securities
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 3 | Certificates of deposit
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 3 | Money market funds
Assets
Cash equivalents:	0	0
Restricted cash equivalents: money market funds	$ 0	$ 0

Fair Value of Financial Asset_4

Fair Value of Financial Assets and Liabilities - Narratrive (Details)	3 Months Ended
	Apr. 30, 2024	Jan. 31, 2024
Salo Sciences
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Performance period	4 years
Private Placement Warrants | Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input	0.700	0.700

Fair Value of Financial Asset_5

Fair Value of Financial Assets and Liabilities - Schedule of Liabilities with Unobservable Inputs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Current portion of contingent consideration	$ 9,695		$ 7,006
Technical Milestone Contingent Consideration
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	5,114	$ 4,433
Change in fair value	(183)	5
Payments	0
Ending balance	4,931	4,438
Customer Contract Earnout Contingent Consideration
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	1,926	3,597
Change in fair value	13	(428)
Payments	(180)
Ending balance	1,759	3,169
Customer Consent Escrow Contingent Consideration
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	5,851	0
Change in fair value	69	0
Payments	0
Ending balance	5,920	0
Salo Sciences | Accrued and Other Current Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Current portion of contingent consideration	9,700		$ 7,000
Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	1,305	9,701
Change in fair value	(771)	(3,323)
Payments	0
Ending balance	$ 534	$ 6,378

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Property, Plant and Equipment [Line Items]
Restricted cash	$ 18,400		$ 18,300
Depreciation	11,000	$ 8,700
Capitalized computer software, amortization	600	500
Amortization of intangible assets	1,500	1,100
Goodwill acquired	$ 1,068	0
Property, Plant and Equipment | Geographic Concentration Risk | United States
Property, Plant and Equipment [Line Items]
Concentration risk	10%		10%
Sinergise
Property, Plant and Equipment [Line Items]
Restricted cash	$ 12,500		$ 12,500
Satellites
Property, Plant and Equipment [Line Items]
Depreciation	10,300	$ 8,200
Money market funds
Property, Plant and Equipment [Line Items]
Restricted cash	$ 4,000		$ 4,000

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Cash and Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024	Apr. 30, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and cash equivalents	$ 107,367	$ 83,866
Restricted cash and cash equivalents, current	8,802	8,360
Restricted cash and cash equivalents, non-current	9,564	9,972
Total cash, cash equivalents, and restricted cash and cash equivalents	$ 125,733	$ 102,198	$ 146,470	$ 188,076

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Short-term Investments (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Short-Term Debt [Line Items]
Cost or Amortized Cost	$ 168,479	$ 214,790
Gains	78	511
Losses	(339)	(260)
Short-term investments	168,218	215,041
U.S. Treasury securities
Short-Term Debt [Line Items]
Cost or Amortized Cost	40,239	46,185
Gains	0	118
Losses	(164)	(92)
Short-term investments	40,075	46,211
Commercial paper
Short-Term Debt [Line Items]
Cost or Amortized Cost	9,777	11,126
Gains	0	0
Losses	0	0
Short-term investments	9,777	11,126
Corporate bonds
Short-Term Debt [Line Items]
Cost or Amortized Cost	109,082	144,119
Gains	78	376
Losses	(154)	(155)
Short-term investments	109,006	144,340
U.S. government agency securities
Short-Term Debt [Line Items]
Cost or Amortized Cost	4,868	9,928
Gains	0	17
Losses	(21)	(13)
Short-term investments	4,847	9,932
Certificates of deposit
Short-Term Debt [Line Items]
Cost or Amortized Cost	4,513	3,432
Gains	0	0
Losses	0	0
Short-term investments	$ 4,513	$ 3,432

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Contracted Maturities (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Amortized Cost
Due in 1 year or less	$ 118,836	$ 148,396
Due in 1-2 years	49,643	66,394
Cost or Amortized Cost	168,479	214,790
Fair Value
Due in 1 year or less	118,697	148,296
Due in 1-2 years	49,521	66,745
Short-term investments	$ 168,218	$ 215,041

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 372,330	$ 386,348
Less: Accumulated depreciation	(260,992)	(272,919)
Property and equipment, net	111,338	113,429
United States
Property, Plant and Equipment [Line Items]
Property and equipment, net	104,941	107,070
Rest of world
Property, Plant and Equipment [Line Items]
Property and equipment, net	6,397	6,359
Satellites
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	277,963	300,203
Satellites in process and not placed into service
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	38,873	32,468
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	17,086	17,089
Ground stations and ground station equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	19,889	19,098
Office furniture, equipment and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	9,025	8,044
Computer equipment and purchased software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 9,494	$ 9,446

Balance Sheet Components - Sc_5

Balance Sheet Components - Schedule of Capitalized Software Development (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Capitalized internal-use software	$ 46,704	$ 45,010
Less: Accumulated amortization	(30,638)	(30,037)
Capitalized internal-use software, net	$ 16,066	$ 14,973

Balance Sheet Components - Sc_6

Balance Sheet Components - Schedule of Goodwill and Intangibles (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024	Apr. 30, 2023	Jan. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	$ 63,462	$ 62,985
Intangible assets, accumulated amortization	(31,960)	(30,529)
Intangible assets, foreign currency translation	(99)	(8)
Intangible assets, net carrying amount	31,403	32,448
Goodwill, gross carrying amount	135,981	134,914
Goodwill, accumulated amortization	0	0
Goodwill, foreign currency translation	1,129	1,342
Goodwill, net carrying amount	137,110	136,256	$ 112,748	$ 112,748
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	30,430	30,429
Intangible assets, accumulated amortization	(11,785)	(11,085)
Intangible assets, foreign currency translation	(331)	(220)
Intangible assets, net carrying amount	18,314	19,124
Image library
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	19,500	19,324
Intangible assets, accumulated amortization	(12,237)	(11,852)
Intangible assets, foreign currency translation	282	218
Intangible assets, net carrying amount	7,545	7,690
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	7,143	7,143
Intangible assets, accumulated amortization	(3,912)	(3,715)
Intangible assets, foreign currency translation	(80)	(42)
Intangible assets, net carrying amount	3,151	3,386
Trade names and other
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	6,389	6,089
Intangible assets, accumulated amortization	(4,026)	(3,877)
Intangible assets, foreign currency translation	30	36
Intangible assets, net carrying amount	$ 2,393	$ 2,248

Balance Sheet Components - Sc_7

Balance Sheet Components - Schedule of Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Goodwill [Roll Forward]
Beginning of period	$ 136,256	$ 112,748
Addition	1,068	0
Currency translation adjustment	(214)	0
End of period	$ 137,110	$ 112,748

Balance Sheet Components - Accr

Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Deferred R&D service liability (see Note 7)	$ 8,034	$ 9,923
Payroll and related expenses	5,208	6,882
Deferred hosting costs	5,053	5,007
Withholding taxes and other taxes payable	1,898	3,152
Contingent consideration	9,695	7,006
Other accruals	13,473	12,809
Total accrued and other current liabilities	$ 43,361	$ 44,779

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Leases [Abstract]
Operating lease, cost	$ 2.3	$ 2
Operating lease, payments	2.4	1.1
Right of use assets obtained	$ 0.5	$ 4.8

Leases - Maturities of Operatin

Leases - Maturities of Operating Lease Liabilities (Details) $ in Thousands	Apr. 30, 2024 USD ($)
Leases [Abstract]
Remainder of Fiscal Year 2025	$ 7,268
2026	9,335
2027	6,208
2028	2,042
2029	936
Thereafter	457
Total lease payments	26,246
Less: Imputed interest	(2,864)
Total lease liabilities	$ 23,382
Weighted average remaining lease term (years)	3 years
Weighted average discount rate	8.10%

Research and Development Arra_2

Research and Development Arrangements (Details) $ in Thousands	1 Months Ended	3 Months Ended		12 Months Ended
	Aug. 31, 2022 USD ($) satellite	Apr. 30, 2024 USD ($)	Apr. 30, 2023 USD ($)	Jan. 31, 2024 USD ($)	Dec. 31, 2020 USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development expense incurred		$ 25,589	$ 28,186
Satellites
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Number of satellites | satellite	2
R&D Services Agreement
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development arrangement, fee provided					$ 45,800
Research and development fee recognized		3,200	4,000
Research and development expense incurred		2,300	4,000
Proceeds from feeds received		45,800		$ 45,800
National Aeronautics Space Administration Communication Services Project
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development fee recognized		2,600	3,100
Research and development expense incurred		2,700	$ 3,900
Research and development arrangement funding receivable	$ 40,500
Funding for research and development		$ 15,500		$ 13,900

Commitment and Contingencies -

Commitment and Contingencies - Other Commitments (Details) $ in Thousands	Apr. 30, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of Fiscal Year 2025	$ 26,030
2026	31,190
2027	32,725
2028	33,427
Total purchase commitments	$ 123,372

Warrants (Details)

Warrants (Details)	Mar. 09, 2021 tradingDay tranche $ / shares shares	Apr. 30, 2024 $ / shares shares	Jan. 31, 2024 $ / shares shares
Class of Warrant or Right [Line Items]
Number of tranches | tranche	4
Threshold trading days | tradingDay	20
2020 Convertible Notes
Class of Warrant or Right [Line Items]
Weighted average remaining term		5 years 10 months 24 days
Period 1
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	$ 15
Period 2
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	17
Period 3
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	19
Period 4
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	$ 21
Public Warrants
Class of Warrant or Right [Line Items]
Warrant outstanding (in shares) | shares		6,899,982	6,899,982
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrant outstanding (in shares) | shares	2,966,667	5,933,333	5,933,333
Weighted average remaining term	5 years
Private Placement Warrants, Vesting
Class of Warrant or Right [Line Items]
Warrant outstanding (in shares) | shares		2,966,667	2,966,667
Common Class A | Public Warrants
Class of Warrant or Right [Line Items]
Warrant exercise price (in dollars per share)	$ 11.50
Series D Convertible Preferred Stock | 2020 Convertible Notes
Class of Warrant or Right [Line Items]
Warrant outstanding (in shares) | shares		1,065,594	1,065,594
Series D Convertible Preferred Stock | 2020 Convertible Notes | Convertible Debt
Class of Warrant or Right [Line Items]
Warrant exercise price (in dollars per share)		$ 9.384	$ 9.384
dMY IV, LLC
Class of Warrant or Right [Line Items]
Equity units issued (in shares) | shares	34,500,000
dMY IV, LLC | Redeemable Warrant
Class of Warrant or Right [Line Items]
Equity units issued, shares called per unit (in shares) | shares	0.2
Warrant exercise price (in dollars per share)	$ 10
dMY IV, LLC | Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrant exercise price (in dollars per share)	$ 11.50
Warrant outstanding (in shares) | shares	5,933,333
Sale of stock, price per share (in dollars per share)	$ 1.50
dMY IV, LLC | Common Class A
Class of Warrant or Right [Line Items]
Equity units issued, shares called per unit (in shares) | shares	1

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	1 Months Ended			3 Months Ended
	Jul. 31, 2023	Apr. 30, 2022	Apr. 30, 2017	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024	Jun. 28, 2021
Related Party Transaction [Line Items]
Deferred revenue, revenue recognized				$ 26,200	$ 25,100
Deferred revenue				76,900
Deferred hosting costs in accrued and other current liabilities				5,053		$ 5,007
Deferred hosting costs				9,261		7,101
Cost of revenue				28,757	24,556
Research and development expense recognized				25,589	28,186
Accounts payable and accrued liabilities				2,500		2,500
Google
Related Party Transaction [Line Items]
Related party transaction, agreement term	1 year		5 years
Related party transaction, renewal term		1 year
Deferred revenue	$ 1,000
Google | Maximum
Related Party Transaction [Line Items]
Receivable amount from customer	$ 2,000
Google | Content Licensing
Related Party Transaction [Line Items]
Deferred revenue, revenue recognized					300
Related Party
Related Party Transaction [Line Items]
Hosting and other services				14,300		$ 12,100
Cost of revenue				6,300	5,800
Research and development expense recognized				700	600
Purchase commitment							$ 193,000
Related Party | Hosting and Other Services
Related Party Transaction [Line Items]
Related party costs and expenses				$ 7,000	$ 6,400
Common Class A
Related Party Transaction [Line Items]
Common stock, shares outstanding (in shares)				269,579,722		268,117,905
Google | PlanetLabs
Related Party Transaction [Line Items]
Ownership percentage (greater than)				10%		10%
Google | PlanetLabs | Common Class A
Related Party Transaction [Line Items]
Common stock, shares outstanding (in shares)				31,942,641		31,942,641

Stock-based Compensation - Sche

Stock-based Compensation - Schedule of Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	$ 13,745	$ 15,983
Capitalized to internal-use software development costs and property and equipment	(673)	(627)
Total stock-based compensation expense	13,072	15,356
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	981	917
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	5,731	6,585
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	2,403	3,080
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	$ 4,630	$ 5,401

Stock-based Compensation - Sc_2

Stock-based Compensation - Schedule of Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2024	Jan. 31, 2024
Number of Options
Outstanding, beginning balance (in shares)	26,956,953
Exercised (in shares)	(35,318)
Granted (in shares)	0
Forfeited (in shares)	(99,529)
Outstanding, ending balance (in shares)	26,822,106	26,956,953
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 5.34
Exercised (in dollars per share)	0.56
Granted (in dollars per share)	0
Forfeited (in dollars per share)	4.63
Outstanding, beginning balance (in dollars per share)	$ 5.35	$ 5.34
Outstanding, weighted average remaining term	5 years 6 months	5 years 8 months 12 days
Vested and exercisable, aggregate intrinsic value	$ 200
Vested and exercisable (in shares)	23,867,411
Vested and exercisable (in dollars per share)	$ 4.90
Vested and exercisable, weighted average remaining term	5 years 3 months 18 days
Vested and exercisable, aggregate intrinsic value	$ 200

Stock-based Compensation - Narr

Stock-based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands			1 Months Ended	3 Months Ended
	Dec. 13, 2021 shares	Mar. 09, 2021 tradingDay tranche $ / shares	Apr. 30, 2024 USD ($) shares	Apr. 30, 2024 USD ($) shares	Apr. 30, 2023 USD ($) shares	Jan. 31, 2024 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, options			$ 12,500	$ 12,500
Share-based compensation expense				13,072	$ 15,356
Liability from early exercise of stock options			8,068	$ 8,068		$ 8,964
Unvested shares subject to repurchase (in shares) | shares				827,190
Number of tranches | tranche		4
Threshold trading days | tradingDay		20
Threshold trading days range | tradingDay		30
VanderSat
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period				2 years
Share-based compensation expense					600
Period 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) | $ / shares		$ 15
Period 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) | $ / shares		17
Period 3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) | $ / shares		19
Period 4
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) | $ / shares		$ 21
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				1 year 3 months 18 days
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				3 years 2 months 12 days
Granted (in shares) | shares				23,425,602
Award vesting period				4 years
Share-based compensation expense				$ 10,800	9,400
Costs not yet recognized, award other than options			139,900	$ 139,900
Awards vested (in shares) | shares				2,201,472
Performance vesting Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				10 months 24 days
Granted (in shares) | shares				348,222
Share-based compensation expense				$ 200	0
Costs not yet recognized, award other than options			$ 800	$ 800
Performance vesting Restricted Stock Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of PSU's eligible to vest				0%
Performance vesting Restricted Stock Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of PSU's eligible to vest				125%
Earn-out Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense					$ 2,300
Awards vested (in shares) | shares				0	0
Awards outstanding (in shares) | shares			3,579,424	3,579,424
Share-based Payment Arrangement | VanderSat | Common Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Business combination, equity interests issued and issuable (in shares) | shares	543,391
Shares committed under ESPP | 2024 Employee Stock Purchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				4 months 24 days
Share-based compensation expense				$ 100
Costs not yet recognized, award other than options			$ 300	$ 300
Percentage of compensation contribution			10%
Purchase price of shares as a percentage of fair market value			85%
Offering period			6 months

Stock-based Compensation - Rest

Stock-based Compensation - Restricted Stock Unit Activity (Details) - Restricted Stock Units	3 Months Ended
	Apr. 30, 2024 $ / shares shares
Number of RSUs
Outstanding, beginning balance (in shares) | shares	26,718,766
Vested (in shares) | shares	(2,201,472)
Granted (in shares) | shares	23,425,602
Forfeited (in shares) | shares	(929,481)
Outstanding, ending balance (in shares) | shares	47,013,415
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 4.45
Vested (in dollars per share) | $ / shares	4.92
Granted (in dollars per share) | $ / shares	2.36
Forfeited (in dollars per share) | $ / shares	3.81
Outstanding, ending balance (in dollars per share) | $ / shares	$ 3.40

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Income Tax Disclosure [Abstract]
Income tax expense	$ 442,000	$ 307,000
Unrecognized tax benefits	9,100,000		$ 8,700,000
Income tax examination, penalties and interest accrued	0		0
Income tax examination, penalties and interest expense	$ 0		$ 0

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Schedule of Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Numerator:
Net loss attributable to common stockholders	$ (29,293)	$ (34,444)
Denominator:
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders, basic (in shares)	288,268,718	272,347,977
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders, diluted (in shares)	288,268,718	272,347,977
Basic and diluted net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.10)	$ (0.13)
Basic and diluted net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.10)	$ (0.13)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities (Details) - shares	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	114,938,130	104,975,317
Warrants to purchase Class A common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,065,594	1,065,594
Common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	26,822,106	32,152,247
Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	47,013,415	31,095,675
Performance vesting Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	355,372	0
Shares committed under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	120,204	0
Earn-out Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	25,038,434	25,567,385
dMY Sponsor Earn-out Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	862,500	862,500
Public Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	6,899,982	6,899,982
Private Placement Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	5,933,333	5,933,333
Early exercised common stock options, subject to future vesting
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	827,190	1,194,830
Shares issued in connection with acquisition, subject to future vesting
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	0	203,771